Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Publication | Open Access

DOI Full Paper Access

496

Citations

References

2015

Year

Russell E. Ware, Barry R. Davis, William H. Schultz, R. Clark Brown, Banu Aygün, Sharada A. Sarnaik, Isaac Odame, Beng Fuh, Alex George, William Owen,

The Lancet

Pediatric HematologyHematologyNeurological MonitoringSickle CellHemostasisNeurologyNon-inferiority TrialCerebral Blood FlowMedicineNeurological AssessmentBlood TransfusionPhase 3Health Sciences